Impact of attenuated oxidative damage in aged hematopoietic stem cells
氧化损伤减弱对衰老造血干细胞的影响
基本信息
- 批准号:9770203
- 负责人:
- 金额:$ 5.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AcetylcysteineAddressAgeAntioxidantsAttenuatedBiological AssayBone MarrowCell AgingCell CompartmentationCellsDNA DamageEnsureGoalsHematopoietic stem cellsInterventionLaboratoriesLifeLinkMusStem cellsTestingTissuesTransplantationagedcohortcongenicdrinking waterexperimental studyfunctional lossimprovedinsightmaleoxidative damageperipheral bloodreconstitution
项目摘要
To establish if there are reduced levels of damage in the HSC compartment after N-acetylcysteine treatment, we administered 1mg/mL of NAC in the drinking water to young and aged C57BL/6 male mice. Age-matched non-treated control cohorts were also included in the experiment. Initial FLARE comet experiments assaying for DNA damage demonstrated a significant decrease in the levels of oxidative damage (FPG+) in old HSCs after one month of NAC treatment. We examined the bone marrow for changes in the primitive bone marrow compartments, but do not see any significant differences in the primitive bone marrow compartments assayed. Functional assays of NAC treated HSCs by transplant assays demonstrated no significant changes in functional potential of HSCs with reduced oxidative damage in peripheral blood (Old-NAC vs Old-WT) or in bone marrow analysis in the primary transplant. To test long term potential of HSCs, secondary transplants were performed on 200 donor derived HSCs again 2x105 congenic competitor cells. Peripheral blood analysis again showed no significant differences in either total reconstitution or in lineage composition four months post-secondary transplant. Current efforts are focused on establishing if aged HSC function can be improved by supplementing NAC during the transplant setting, where the HSCs will be actively dividing, and antioxidant benefits may be more pronounced in this setting.
为了确定N-乙酰半胱氨酸治疗后HSC隔室的损伤水平降低,我们对饮用水中的NAC施用了1mg/mL的NAC,以对年轻和年龄的C57BL/6雄性小鼠施用。实验中还包括年龄匹配的未处理对照组。在NAC治疗一个月后,对DNA损伤进行测定的初始耀斑彗星实验表明,旧HSC的氧化损伤水平(FPG+)显着降低。我们检查了骨髓是否有原始骨髓室的变化,但没有看到测定的原始骨髓室的任何显着差异。 通过移植测定对NAC处理的HSC进行的功能测定表明,HSC的功能潜力没有显着变化,而外周血(Old-NAC与Old-WT)的氧化损伤或主要移植中的骨髓分析没有显着变化。为了测试HSC的长期潜力,对200个供体衍生的HSC进行了继发性移植,再次进行了2x105个先天性竞争者细胞。 周围血液分析再次显示出四个月的次生移植后四个月的总重建或谱系组成均无显着差异。当前的努力集中在建立是否可以通过在移植设置中补充NAC来提高老化的HSC功能,而HSC将积极分裂,并且在此环境中可能会更明显。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Isabel Beerman其他文献
Isabel Beerman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Isabel Beerman', 18)}}的其他基金
Impact of attenuated oxidative damage in aged hematopoietic stem cells
氧化损伤减弱对衰老造血干细胞的影响
- 批准号:
9549410 - 财政年份:
- 资助金额:
$ 5.36万 - 项目类别:
Characterization of hematopoietic stem cell (HSC) and progenitor cell aging, identification of candidate age-regulated genes as targets for therapeutic intervention
造血干细胞 (HSC) 和祖细胞衰老的表征,识别候选年龄调节基因作为治疗干预的目标
- 批准号:
10913188 - 财政年份:
- 资助金额:
$ 5.36万 - 项目类别:
Characterization of hematopoietic stem cell (HSC) and progenitor cell aging, identification of candidate age-regulated genes as targets for therapeutic intervention
造血干细胞 (HSC) 和祖细胞衰老的表征,识别候选年龄调节基因作为治疗干预的目标
- 批准号:
10473357 - 财政年份:
- 资助金额:
$ 5.36万 - 项目类别:
Defining epigenetic dysregulation in aged hematopoietic stem cells
定义衰老造血干细胞的表观遗传失调
- 批准号:
9549404 - 财政年份:
- 资助金额:
$ 5.36万 - 项目类别:
Characterization of hematopoietic stem cell (HSC) and progenitor cell aging, identification of candidate age-regulated genes as targets for therapeutic intervention
造血干细胞 (HSC) 和祖细胞衰老的表征,识别候选年龄调节基因作为治疗干预的目标
- 批准号:
10250929 - 财政年份:
- 资助金额:
$ 5.36万 - 项目类别:
Defining epigenetic dysregulation in aged hematopoietic stem cells
定义衰老造血干细胞的表观遗传失调
- 批准号:
10252566 - 财政年份:
- 资助金额:
$ 5.36万 - 项目类别:
Defining epigenetic dysregulation in aged hematopoietic stem cells
定义衰老造血干细胞的表观遗传失调
- 批准号:
10688897 - 财政年份:
- 资助金额:
$ 5.36万 - 项目类别:
Characterization of hematopoietic stem cell (HSC) and progenitor cell aging, identification of candidate age-regulated genes as targets for therapeutic intervention
造血干细胞 (HSC) 和祖细胞衰老的表征,识别候选年龄调节基因作为治疗干预的目标
- 批准号:
10688900 - 财政年份:
- 资助金额:
$ 5.36万 - 项目类别:
Characterization of hematopoietic stem cell (HSC) and progenitor cell aging, identification of candidate age-regulated genes as targets for therapeutic intervention
造血干细胞 (HSC) 和祖细胞衰老的表征,识别候选年龄调节基因作为治疗干预的目标
- 批准号:
9549412 - 财政年份:
- 资助金额:
$ 5.36万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Deciphering the role of mitochondrial/autophagy dysfunction in regulating inflammatory processes during AMD pathogenesis
破译线粒体/自噬功能障碍在 AMD 发病机制中调节炎症过程中的作用
- 批准号:
10664118 - 财政年份:2023
- 资助金额:
$ 5.36万 - 项目类别:
Basis of sex-specific therapeutic responses to obstructive sleep apnea: Oxidative stress, inflammation, and vascular function
阻塞性睡眠呼吸暂停的性别特异性治疗反应的基础:氧化应激、炎症和血管功能
- 批准号:
10930195 - 财政年份:2023
- 资助金额:
$ 5.36万 - 项目类别:
NAC Attack, A Phase-3, Multicenter, Randomized, Placebo-Controlled Trial in Patents with Retinitis Pigmentosa
NAC Attack,针对色素性视网膜炎的 3 期、多中心、随机、安慰剂对照试验
- 批准号:
10333382 - 财政年份:2022
- 资助金额:
$ 5.36万 - 项目类别:
NAC Attack, A Phase-3, Multicenter, Randomized, Placebo-Controlled Trial in Patents with Retinitis Pigmentosa
NAC Attack,针对色素性视网膜炎的 3 期、多中心、随机、安慰剂对照试验
- 批准号:
10593947 - 财政年份:2022
- 资助金额:
$ 5.36万 - 项目类别: